Dose-response association of acute-phase quetiapine treatment with risk of new-onset hypothyroidism in schizophrenia patients.

导出原文传递

翻译打印收藏纠错

作者： Ying,Zhao ^[1] ; Shi Wu,Wen ^[2] ; Mengzhe,Li ^[3] ; Zhongyu,Sun ^[4] ; Xiang,Yuan ^[5] ; Ravi,Retnakaran ^[6] ; Ruiling,Zhang ^[7] ; Desheng,Zhai ^[7]

作者单位： The Second Affiliated Hospital, Xinxiang Medical University, Xinxiang, 453002, China. ^[1] School of Pharmacy, Xinxiang Medical University, Xinxiang, 453003, China. ^[2] Xinxiang Key Laboratory of Clinical psychopharmacology, Xinxiang, 453003, China. ^[3] OMNI Research Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada. ^[4] School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, Canada. ^[5] Department of Obstetrics, Gynecology, and Newborn Care, University of Ottawa Faculty of Medicine, Ottawa, Canada. ^[6] School of Public Health, Xinxiang Medical University, Xinxiang, 453003, China. ^[7] The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, 471003, China. ^[8] Division of Endocrinology and Metabolism, University of Toronto, Toronto, Canada. ^[9] Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada. ^[10]

关键词 dose-response hypothyroidism quetiapine schizophrenia

主题词人类(Humans);甲状腺功能减退症(Hypothyroidism);回顾性研究(Retrospective Studies);精神分裂症(Schizophrenia);甲状腺素(Thyroxine)

DOI 10.1111/bcp.14928

PMID 34046922

发布时间 2022-05-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交